Adjuvants for viral vaccines

Details Adjuvants for viral vaccines Adjuvants for viral vaccines

1995-06-02

1998-02-17

Smith, Lynette F.

Drug, bio-affecting and body treating compositions

Nonspecific immunoeffector, per se ; or nonspecific...

4242811, 4241881, A61K 4500, A61K 4505, A61K 3921, A61K 4700

Patent

active

057189048

ABSTRACT:
The present invention discloses mammalian vaccine compositions having an effective amount of an adjuvant, the adjuvant comprising squalene or squlane, glycerol and a surfactant. These compositions also optionally contain an aluminum salt and one or more pharmaceutically acceptable buffers.

REFERENCES:
patent: 4073743 (1978-02-01), Midler et al.
patent: 4466957 (1984-08-01), Hjorth et al.
patent: 5376369 (1994-12-01), Allison et al.
Bull. Org. Mond. Sante/Bull. Wld. Hlth. Org., 41, 617-621, 1969.
The Lancet, vol. 344, Jul. 16, 1994, 160-163.
Vaccine, vol. 11, Issue 3, 1993, 293-306.
Journal of Clinical Microbiology, vol. 13, No. 1, 54-57, Jan. 1981.
Infection and Immunity, vol. 28, No. 3, 937-943, 1980.
Proc. Natl. Acad. Sci., vol. 89, 8308-8312, 1992.
Vaccines, vol. 11, Issue 13, 1302-1309, 1993.
Bio/Technology, vol. 5, Oct. 1987.
Vaccines 92, Copyright 1992.
Vaccines, Plenum Press, New York, 1991.
Vaccines, vol. 11, 9, 909-913, 1993.

Affiliated with

Also associated with

Rating

Adjuvants for viral vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adjuvants for viral vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adjuvants for viral vaccines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1782398